Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

Clarivate Plc  a leading global provider of transformative intelligence, in partnership with Healthcare Executive, published by the China Pharmaceutical Enterprises Association, today announced the ...

Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials ... completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for ...

Clene (NASDAQ:CLNN – Free Report) had its price target cut by Canaccord Genuity Group from $86.00 to $83.00 in a research report released on Thursday morning,Benzinga reports. They currently have a ...

Karyopharm Therapeutics Inc. (Nasdaq: KPTI ), a commercial-stage Pharmaceutical company pioneering novel cancer therapies, today announced abstracts detailing selinexor data have been selected to be ...

The ATTR-PN cohort also reflected similar positive trends with a mean TTR reduction of 91% and improvements in neuropathy measures. These promising results ... therapeutic applications of CRISPR or ...

ELAHERE is the first and only novel therapy approved in the European Union specifically for patients with folate receptor-alpha (FR?) positive, platinum-resistant ovarian cancerELAHERE represents the ...

Completed Enrollment of Dose Escalation Part of Phase 1 Clinical Trial of its Next-Generation Nectin-4 Targeting ADC (CRB-701 ...